Menu
 

Search abstracts


High risk medicines: supporting patients and prescribers on a novel class of oral anticoagulants

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: COELHO, Cristina (NHS Greater Glasgow and Clyde, Pharmacy and Prescribing Support Unit)
  • Co-author(s): Cristina Coelho: Pharmacy and Prescribing Support Unit, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Elaine McIvor: Pharmacy and Prescribing Support Unit, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Steve McGlynn: Pharmacy and Prescribing Support Unit, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Yvonne Semple: Pharmacy and Prescribing Support Unit, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Campbell Tait: Department of Haematology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    David Murdoch: Department of Cardiology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
  • Abstract:

    Background

    Direct oral anticoagulants (DOACs) are a new class of medicines to prevent and treat blood clots. DOACs are considered high risk medicines due to the potential for causing a bleed. Risks associated with warfarin are highlighted to UK patients using a Patient Booklet and Alert Card (PB&AC).  There are no equivalent materials for patients..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses